PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40123C00184Characterize naloxones clinical USE RISKS — American College of Medical Toxicology, Inc

American College of Medical Toxicology, Inc holds $6.2M across 10 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 29, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fda Office Of Acq Grant Svcs
Awarding office
American College of Medical Toxicology, Inc
Recipient
Sep 29, 2026
PoP end
$4M
Obligated
$4M
Potential
541990
NAICS
AN41
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75F40123C00184
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentAmerican College of Medical Toxicology, Inc
CAGE51Y63
UEISENNVSJDUES4
NAICS541990

No full NAICS 541990 intel page yet. Browse NAICS intelligence

PSCAN41
Place of performanceSILVER SPRING MD
Pricing typeCost No Fee
Extent competedFull And Open Competition
PoP startSep 25, 2023
PoP end (current)Sep 29, 2026
PoP end (w/ options)Sep 29, 2027
Obligated$4M
Current value$4M
Potential value$4M

CHARACTERIZE NALOXONES CLINICAL USE, RISKS, BENEFITS, AND EFFECTIVENESS FOR REVERSING OPIOID OVERDOSES IN PRE-HOSPITAL SETTINGS. USING QUALITATIVE AND QUANTITATIVE BLOOD TOXICOLOGY TESTS, DETERMINE THE RISKS, BENEFITS, EFFECTIVENESS OF HIGH DOSE NAL is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by American College of Medical Toxicology, Inc. Estimated value $4M ($4M obligated). Current period of performance ends Sep 29, 2026 (potential Sep 29, 2027). Last award drew 1 bidder. Place of performance: SILVER SPRING MD.

CHARACTERIZE NALOXONES CLINICAL USE, RISKS, BENEFITS, AND EFFECTIVENESS FOR REVERSING OPIOID OVERDOSES IN PRE-HOSPITAL SETTINGS. USING QUALITATIVE AND QUANTITATIVE BLOOD TOXICOLOGY TESTS, DETERMINE THE RISKS, BENEFITS, EFFECTIVENESS OF HIGH DOSE NAL

Recompete timing

Public
● Expiring in 1 days

Current PoP ends Sep 29, 2026 (1 days remaining). Agencies typically plan 12–18 months ahead — at 0.0 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75F40123C00184? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

American College of Medical Toxicology, Inc — $6.2M obligated across 10 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$6.2M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
75D30123C16380
TOXIC REGISTRY ACCESS
$2.3M
Jun 28, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40123C00184?

75F40123C00184 (Characterize naloxones clinical USE RISKS) is a Fda Office Of Acq Grant Svcs award with a potential value of $4M, currently held by American College of Medical Toxicology, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40123C00184?

Fda Office Of Acq Grant Svcs awarded 75F40123C00184 to American College of Medical Toxicology, Inc (potential $4M).

Who is the incumbent on 75F40123C00184?

American College of Medical Toxicology, Inc is the incumbent with $6.2M across 10 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does American College of Medical Toxicology, Inc’s 75F40123C00184 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40123C00184? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40123C00184